Senior insider sale
Chief Development Officer at RAPPORT THERAPEUTICS, INC. — senior position signals high conviction
$102.5K
2.09K shares
What this filing means
YELESWARAM KRISHNASWAMY plans to sell 2.09K shares of RAPPORT THERAPEUTICS, INC. valued at approximately $102.5K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 8/19/2026ACC: 0001950047-26-008426
Officer· Chief Development Officer
Since Feb 2026
2.09K
Shares to sell
$102.5K
Approx. market value
2.09K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Founders Shares
N/A
6/9/2024
2.09KTotal acquired2.09K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
6/9/2024 | Founders Shares N/A | 2.09K | — |
| Total | 2.09K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
2.09K
Market value
$102.5K
8/19/2026
Total
Units
2.09K
Value
$102.5K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
8/19/2026 | 2.09K | $102.5K | NASDAQ | Planned |
| Total | 2.09K | $102.5K | ||